AKT1 and thyroid cancer: The molecular pathogenesis of most thyroid cancer involves mitogen activated protein kinase (MAPK) and phosphatidylinositide 3-kinases/protein kinase B (Sui et al., 2014), PI3K/Akt signaling pathway (Petrulea et al., 2015) is out of balance.